Detalles de la búsqueda
1.
Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson's disease.
J Pharmacokinet Pharmacodyn;
2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578533
2.
Convolution-based approach for modeling the paliperidone extended release and Long-Acting Injectable (LAI) PK of once-, and three-monthly products administration and for optimizing the development of new LAI products.
J Pharmacokinet Pharmacodyn;
50(2): 89-96, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484885
3.
A post hoc analysis of the effect of viloxazine extended-release capsules on learning and school problems in children and adolescents with attention-deficit/hyperactivity disorder.
Eur Child Adolesc Psychiatry;
32(3): 491-499, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34581911
4.
The role of placebo response in the efficacy outcome assessment in viloxazine extended-release pivotal trials in paediatric subjects with attention-deficit/hyperactivity disorder.
Br J Clin Pharmacol;
88(11): 4828-4838, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35588245
5.
Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder.
J Clin Psychopharmacol;
40(4): 350-358, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32590405
6.
Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.
J Pharmacokinet Pharmacodyn;
47(3): 189-198, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32435882
7.
Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modelling of the novel H4 receptor inhibitor SENS-111 using a modified caloric test in healthy subjects.
Br J Clin Pharmacol;
84(12): 2836-2848, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30152527
8.
Continuous-time Markov modelling of flexible-dose depression trials.
J Pharmacokinet Pharmacodyn;
41(6): 625-38, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25281421
9.
A convolution-based in vitro-in vivo correlation model for methylphenidate hydrochloride delayed-release and extended-release capsule.
CPT Pharmacometrics Syst Pharmacol;
13(1): 132-142, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37864318
10.
Advanced Model-based Approach to Evaluate Human Plasma, Cerebrospinal Fluid, and Neuronal mTORC1 Activation Biomarkers After NV-5138 Administration in Healthy Volunteers.
Clin Ther;
46(3): 217-227, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485588
11.
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.
J Pharmacol Exp Ther;
346(2): 311-7, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23685546
12.
Exposure-response modeling of anti-depressant treatments: the confounding role of placebo effect.
J Pharmacokinet Pharmacodyn;
40(3): 389-99, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23263774
13.
A PCA approach to population analysis: with application to a Phase II depression trial.
J Pharmacokinet Pharmacodyn;
40(2): 213-27, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23504512
14.
Artificial intelligence approach for the analysis of placebo-controlled clinical trials in major depressive disorders accounting for individual propensity to respond to placebo.
Transl Psychiatry;
13(1): 141, 2023 04 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120641
15.
A new method for analyzing clinical trials in depression based on individual propensity to respond to placebo estimated using artificial intelligence.
Psychiatry Res;
327: 115367, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37544088
16.
Interpreting clinical trial outcomes complicated by placebo response with an assessment of false-negative and true-negative clinical trials in depression using propensity-weighting.
Transl Psychiatry;
13(1): 388, 2023 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38097546
17.
Response of peer relations and social activities to treatment with viloxazine extended-release capsules (Qelbree® ): A post hoc analysis of four randomized clinical trials of children and adolescents with attention-deficit/hyperactivity disorder.
Brain Behav;
13(4): e2910, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36847750
18.
Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day.
J Child Adolesc Psychopharmacol;
33(1): 14-19, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36730749
19.
A pharmacokinetic PET study of NK1 receptor occupancy.
Eur J Nucl Med Mol Imaging;
39(2): 226-35, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21993526
20.
Modeling Alzheimer's disease progression using the disease system analysis approach.
Alzheimers Dement;
8(1): 39-50, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21782528